EQRx's Aumolertinib May Be A Serious Competitive Contender For Tagrisso

Storm clouds
A new competitive threat is brewing for Tagrisso • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASCO

More from Conferences